Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma

BACKGROUND: Allergen-specific immunotherapy (AIT) is the only curative treatment for type-1 allergies, but sometimes shows limited therapeutic response as well as local and systemic side effects. Limited control of local inflammation and patient symptoms hampers its widespread use in severe allergic...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar-Pimentel, Antonio, Graessel, Anke, Alessandrini, Francesca, Fuchs, Helmut, Gailus-Durner, Valerie, Hrabě de Angelis, Martin, Russkamp, Dennis, Chaker, Adam, Ollert, Markus, Blank, Simon, Gutermuth, Jan, Schmidt-Weber, Carsten B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453633/
https://www.ncbi.nlm.nih.gov/pubmed/28570653
http://dx.doi.org/10.1371/journal.pone.0178563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453633/
https://www.ncbi.nlm.nih.gov/pubmed/28570653
http://dx.doi.org/10.1371/journal.pone.0178563

Ejemplares similares